Clinical Trials Directory

Trials / Sponsors / Avalo Therapeutics, Inc.

Avalo Therapeutics, Inc.

Industry · 10 registered clinical trials.

StatusTrialPhaseStarted
Active Not RecruitingA Study to Evaluate the Efficacy and Safety of AVTX-009 in Patients With Moderate to Severe Hidradenitis Suppu
Hidradenitis Suppurativa
Phase 22024-09-16
CompletedA Study to Evaluate the Safety and Efficacy of AVTX-002 for the Treatment of Poorly Controlled Non-Eosinophili
Non-Eosinophilic Asthma
Phase 22022-02-24
WithdrawnA Pharmacokinetic, Pharmacodynamic, Safety and Tolerability Study of CERC-006 in Adults With Complex Lymphatic
Lymphatic Malformation
Phase 12021-09-03
CompletedPhase 1b Study of AEVI-007 in Subjects With Relapsed or Refractory Multiple Myeloma
Multiple Myeloma
Phase 12020-12-15
TerminatedEvaluation of the Safety, Tolerability, and Efficacy of MDGN-002 in Adults With Moderate to Severe Active Croh
Crohn Disease, Ulcerative Colitis
Phase 12017-07-14
CompletedA Study of Intermittent Doses of CERC-301 in MDD
Major Depressive Disorder
Phase 22015-06-01
CompletedA Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatm
Major Depressive Disorder
Phase 22013-11-01
CompletedAn Exploratory Study of FP01 Lozenges in Subjects With Chronic Refractory Cough
Chronic Refractory Cough
Phase 22012-11-01
CompletedAntitussive Effects of FP01 Lozenges in Subjects With Cough Due to Upper Respiratory Tract Infection
Acute Cough
Phase 22012-05-01
CompletedA Single Dose Study to Determine the Safety and Pharmacokinetics of FP01 Lozenges in Healthy Volunteers
Healthy
Phase 12012-04-01